The global market for H1N1 Influenza A Vaccine was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

North American market for H1N1 Influenza A Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for H1N1 Influenza A Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of H1N1 Influenza A Vaccine include Sanofi, Beijing Institute of Biological Products, Sinovac Biotech, Fosun Yalifeng (Dalian) Biopharmaceutical, Shanghai Institute Of Biological Products, Hualan Biological Engineering, Lanzhou Biological Products, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for H1N1 Influenza A Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding H1N1 Influenza A Vaccine.

The H1N1 Influenza A Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global H1N1 Influenza A Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the H1N1 Influenza A Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of H1N1 Influenza A Vaccine Market Report

Report Metric	Details
Report Name	H1N1 Influenza A Vaccine Market
Segment by Type	0.5mL/Tube Others
Segment by Application	Underage Aldult
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Sanofi, Beijing Institute of Biological Products, Sinovac Biotech, Fosun Yalifeng (Dalian) Biopharmaceutical, Shanghai Institute Of Biological Products, Hualan Biological Engineering, Lanzhou Biological Products
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of H1N1 Influenza A Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of H1N1 Influenza A Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the H1N1 Influenza A Vaccine Market report?

Ans: The main players in the H1N1 Influenza A Vaccine Market are Sanofi, Beijing Institute of Biological Products, Sinovac Biotech, Fosun Yalifeng (Dalian) Biopharmaceutical, Shanghai Institute Of Biological Products, Hualan Biological Engineering, Lanzhou Biological Products

What are the Application segmentation covered in the H1N1 Influenza A Vaccine Market report?

Ans: The Applications covered in the H1N1 Influenza A Vaccine Market report are Underage, Aldult

What are the Type segmentation covered in the H1N1 Influenza A Vaccine Market report?

Ans: The Types covered in the H1N1 Influenza A Vaccine Market report are 0.5mL/Tube, Others

1 H1N1 Influenza A Vaccine Market Overview

1.1 Product Definition

1.2 H1N1 Influenza A Vaccine by Type

1.2.1 Global H1N1 Influenza A Vaccine Market Value Comparison by Type (2024 VS 2031)

1.2.2 0.5mL/Tube

1.2.3 Others

1.3 H1N1 Influenza A Vaccine by Application

1.3.1 Global H1N1 Influenza A Vaccine Market Value by Application (2024 VS 2031)

1.3.2 Underage

1.3.3 Aldult

1.4 Global H1N1 Influenza A Vaccine Market Size Estimates and Forecasts

1.4.1 Global H1N1 Influenza A Vaccine Revenue 2020-2031

1.4.2 Global H1N1 Influenza A Vaccine Sales 2020-2031

1.4.3 Global H1N1 Influenza A Vaccine Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 H1N1 Influenza A Vaccine Market Competition by Manufacturers

2.1 Global H1N1 Influenza A Vaccine Sales Market Share by Manufacturers (2020-2025)

2.2 Global H1N1 Influenza A Vaccine Revenue Market Share by Manufacturers (2020-2025)

2.3 Global H1N1 Influenza A Vaccine Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of H1N1 Influenza A Vaccine, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of H1N1 Influenza A Vaccine, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of H1N1 Influenza A Vaccine, Product Type & Application

2.7 Global Key Manufacturers of H1N1 Influenza A Vaccine, Date of Enter into This Industry

2.8 Global H1N1 Influenza A Vaccine Market Competitive Situation and Trends

2.8.1 Global H1N1 Influenza A Vaccine Market Concentration Rate

2.8.2 The Global 5 and 10 Largest H1N1 Influenza A Vaccine Players Market Share by Revenue

2.8.3 Global H1N1 Influenza A Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global H1N1 Influenza A Vaccine Market Scenario by Region

3.1 Global H1N1 Influenza A Vaccine Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global H1N1 Influenza A Vaccine Sales by Region: 2020-2031

3.2.1 Global H1N1 Influenza A Vaccine Sales by Region: 2020-2025

3.2.2 Global H1N1 Influenza A Vaccine Sales by Region: 2026-2031

3.3 Global H1N1 Influenza A Vaccine Revenue by Region: 2020-2031

3.3.1 Global H1N1 Influenza A Vaccine Revenue by Region: 2020-2025

3.3.2 Global H1N1 Influenza A Vaccine Revenue by Region: 2026-2031

3.4 North America H1N1 Influenza A Vaccine Market Facts & Figures by Country

3.4.1 North America H1N1 Influenza A Vaccine Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America H1N1 Influenza A Vaccine Sales by Country (2020-2031)

3.4.3 North America H1N1 Influenza A Vaccine Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe H1N1 Influenza A Vaccine Market Facts & Figures by Country

3.5.1 Europe H1N1 Influenza A Vaccine Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe H1N1 Influenza A Vaccine Sales by Country (2020-2031)

3.5.3 Europe H1N1 Influenza A Vaccine Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific H1N1 Influenza A Vaccine Market Facts & Figures by Region

3.6.1 Asia Pacific H1N1 Influenza A Vaccine Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific H1N1 Influenza A Vaccine Sales by Region (2020-2031)

3.6.3 Asia Pacific H1N1 Influenza A Vaccine Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America H1N1 Influenza A Vaccine Market Facts & Figures by Country

3.7.1 Latin America H1N1 Influenza A Vaccine Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America H1N1 Influenza A Vaccine Sales by Country (2020-2031)

3.7.3 Latin America H1N1 Influenza A Vaccine Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa H1N1 Influenza A Vaccine Market Facts & Figures by Country

3.8.1 Middle East and Africa H1N1 Influenza A Vaccine Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa H1N1 Influenza A Vaccine Sales by Country (2020-2031)

3.8.3 Middle East and Africa H1N1 Influenza A Vaccine Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global H1N1 Influenza A Vaccine Sales by Type (2020-2031)

4.1.1 Global H1N1 Influenza A Vaccine Sales by Type (2020-2025)

4.1.2 Global H1N1 Influenza A Vaccine Sales by Type (2026-2031)

4.1.3 Global H1N1 Influenza A Vaccine Sales Market Share by Type (2020-2031)

4.2 Global H1N1 Influenza A Vaccine Revenue by Type (2020-2031)

4.2.1 Global H1N1 Influenza A Vaccine Revenue by Type (2020-2025)

4.2.2 Global H1N1 Influenza A Vaccine Revenue by Type (2026-2031)

4.2.3 Global H1N1 Influenza A Vaccine Revenue Market Share by Type (2020-2031)

4.3 Global H1N1 Influenza A Vaccine Price by Type (2020-2031)

5 Segment by Application

5.1 Global H1N1 Influenza A Vaccine Sales by Application (2020-2031)

5.1.1 Global H1N1 Influenza A Vaccine Sales by Application (2020-2025)

5.1.2 Global H1N1 Influenza A Vaccine Sales by Application (2026-2031)

5.1.3 Global H1N1 Influenza A Vaccine Sales Market Share by Application (2020-2031)

5.2 Global H1N1 Influenza A Vaccine Revenue by Application (2020-2031)

5.2.1 Global H1N1 Influenza A Vaccine Revenue by Application (2020-2025)

5.2.2 Global H1N1 Influenza A Vaccine Revenue by Application (2026-2031)

5.2.3 Global H1N1 Influenza A Vaccine Revenue Market Share by Application (2020-2031)

5.3 Global H1N1 Influenza A Vaccine Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Sanofi

6.1.1 Sanofi Company Information

6.1.2 Sanofi Description and Business Overview

6.1.3 Sanofi H1N1 Influenza A Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Sanofi H1N1 Influenza A Vaccine Product Portfolio

6.1.5 Sanofi Recent Developments/Updates

6.2 Beijing Institute of Biological Products

6.2.1 Beijing Institute of Biological Products Company Information

6.2.2 Beijing Institute of Biological Products Description and Business Overview

6.2.3 Beijing Institute of Biological Products H1N1 Influenza A Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Beijing Institute of Biological Products H1N1 Influenza A Vaccine Product Portfolio

6.2.5 Beijing Institute of Biological Products Recent Developments/Updates

6.3 Sinovac Biotech

6.3.1 Sinovac Biotech Company Information

6.3.2 Sinovac Biotech Description and Business Overview

6.3.3 Sinovac Biotech H1N1 Influenza A Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Sinovac Biotech H1N1 Influenza A Vaccine Product Portfolio

6.3.5 Sinovac Biotech Recent Developments/Updates

6.4 Fosun Yalifeng (Dalian) Biopharmaceutical

6.4.1 Fosun Yalifeng (Dalian) Biopharmaceutical Company Information

6.4.2 Fosun Yalifeng (Dalian) Biopharmaceutical Description and Business Overview

6.4.3 Fosun Yalifeng (Dalian) Biopharmaceutical H1N1 Influenza A Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Fosun Yalifeng (Dalian) Biopharmaceutical H1N1 Influenza A Vaccine Product Portfolio

6.4.5 Fosun Yalifeng (Dalian) Biopharmaceutical Recent Developments/Updates

6.5 Shanghai Institute Of Biological Products

6.5.1 Shanghai Institute Of Biological Products Company Information

6.5.2 Shanghai Institute Of Biological Products Description and Business Overview

6.5.3 Shanghai Institute Of Biological Products H1N1 Influenza A Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Shanghai Institute Of Biological Products H1N1 Influenza A Vaccine Product Portfolio

6.5.5 Shanghai Institute Of Biological Products Recent Developments/Updates

6.6 Hualan Biological Engineering

6.6.1 Hualan Biological Engineering Company Information

6.6.2 Hualan Biological Engineering Description and Business Overview

6.6.3 Hualan Biological Engineering H1N1 Influenza A Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Hualan Biological Engineering H1N1 Influenza A Vaccine Product Portfolio

6.6.5 Hualan Biological Engineering Recent Developments/Updates

6.7 Lanzhou Biological Products

6.7.1 Lanzhou Biological Products Company Information

6.7.2 Lanzhou Biological Products Description and Business Overview

6.7.3 Lanzhou Biological Products H1N1 Influenza A Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Lanzhou Biological Products H1N1 Influenza A Vaccine Product Portfolio

6.7.5 Lanzhou Biological Products Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 H1N1 Influenza A Vaccine Industry Chain Analysis

7.2 H1N1 Influenza A Vaccine Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 H1N1 Influenza A Vaccine Production Mode & Process Analysis

7.4 H1N1 Influenza A Vaccine Sales and Marketing

7.4.1 H1N1 Influenza A Vaccine Sales Channels

7.4.2 H1N1 Influenza A Vaccine Distributors

7.5 H1N1 Influenza A Vaccine Customer Analysis

8 H1N1 Influenza A Vaccine Market Dynamics

8.1 H1N1 Influenza A Vaccine Industry Trends

8.2 H1N1 Influenza A Vaccine Market Drivers

8.3 H1N1 Influenza A Vaccine Market Challenges

8.4 H1N1 Influenza A Vaccine Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Sanofi

Beijing Institute of Biological Products

SINOVAC BIOTECH

Shanghai Institute of Biological Products

Hualan Biological Engineering

Fosun Yalifeng (Dalian) Biopharmaceutical

Lanzhou Biological Products

List of Tables

Table 1. Global H1N1 Influenza A Vaccine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global H1N1 Influenza A Vaccine Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global H1N1 Influenza A Vaccine Market Competitive Situation by Manufacturers in 2024

Table 4. Global H1N1 Influenza A Vaccine Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global H1N1 Influenza A Vaccine Sales Market Share by Manufacturers (2020-2025)

Table 6. Global H1N1 Influenza A Vaccine Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global H1N1 Influenza A Vaccine Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market H1N1 Influenza A Vaccine Average Price (US$/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of H1N1 Influenza A Vaccine, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of H1N1 Influenza A Vaccine, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of H1N1 Influenza A Vaccine, Product Type & Application

Table 12. Global Key Manufacturers of H1N1 Influenza A Vaccine, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global H1N1 Influenza A Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in H1N1 Influenza A Vaccine as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global H1N1 Influenza A Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global H1N1 Influenza A Vaccine Sales by Region (2020-2025) & (K Units)

Table 18. Global H1N1 Influenza A Vaccine Sales Market Share by Region (2020-2025)

Table 19. Global H1N1 Influenza A Vaccine Sales by Region (2026-2031) & (K Units)

Table 20. Global H1N1 Influenza A Vaccine Sales Market Share by Region (2026-2031)

Table 21. Global H1N1 Influenza A Vaccine Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global H1N1 Influenza A Vaccine Revenue Market Share by Region (2020-2025)

Table 23. Global H1N1 Influenza A Vaccine Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global H1N1 Influenza A Vaccine Revenue Market Share by Region (2026-2031)

Table 25. North America H1N1 Influenza A Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America H1N1 Influenza A Vaccine Sales by Country (2020-2025) & (K Units)

Table 27. North America H1N1 Influenza A Vaccine Sales by Country (2026-2031) & (K Units)

Table 28. North America H1N1 Influenza A Vaccine Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America H1N1 Influenza A Vaccine Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe H1N1 Influenza A Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe H1N1 Influenza A Vaccine Sales by Country (2020-2025) & (K Units)

Table 32. Europe H1N1 Influenza A Vaccine Sales by Country (2026-2031) & (K Units)

Table 33. Europe H1N1 Influenza A Vaccine Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe H1N1 Influenza A Vaccine Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific H1N1 Influenza A Vaccine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific H1N1 Influenza A Vaccine Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific H1N1 Influenza A Vaccine Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific H1N1 Influenza A Vaccine Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific H1N1 Influenza A Vaccine Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America H1N1 Influenza A Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America H1N1 Influenza A Vaccine Sales by Country (2020-2025) & (K Units)

Table 42. Latin America H1N1 Influenza A Vaccine Sales by Country (2026-2031) & (K Units)

Table 43. Latin America H1N1 Influenza A Vaccine Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America H1N1 Influenza A Vaccine Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa H1N1 Influenza A Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa H1N1 Influenza A Vaccine Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa H1N1 Influenza A Vaccine Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa H1N1 Influenza A Vaccine Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa H1N1 Influenza A Vaccine Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global H1N1 Influenza A Vaccine Sales (K Units) by Type (2020-2025)

Table 51. Global H1N1 Influenza A Vaccine Sales (K Units) by Type (2026-2031)

Table 52. Global H1N1 Influenza A Vaccine Sales Market Share by Type (2020-2025)

Table 53. Global H1N1 Influenza A Vaccine Sales Market Share by Type (2026-2031)

Table 54. Global H1N1 Influenza A Vaccine Revenue (US$ Million) by Type (2020-2025)

Table 55. Global H1N1 Influenza A Vaccine Revenue (US$ Million) by Type (2026-2031)

Table 56. Global H1N1 Influenza A Vaccine Revenue Market Share by Type (2020-2025)

Table 57. Global H1N1 Influenza A Vaccine Revenue Market Share by Type (2026-2031)

Table 58. Global H1N1 Influenza A Vaccine Price (US$/Unit) by Type (2020-2025)

Table 59. Global H1N1 Influenza A Vaccine Price (US$/Unit) by Type (2026-2031)

Table 60. Global H1N1 Influenza A Vaccine Sales (K Units) by Application (2020-2025)

Table 61. Global H1N1 Influenza A Vaccine Sales (K Units) by Application (2026-2031)

Table 62. Global H1N1 Influenza A Vaccine Sales Market Share by Application (2020-2025)

Table 63. Global H1N1 Influenza A Vaccine Sales Market Share by Application (2026-2031)

Table 64. Global H1N1 Influenza A Vaccine Revenue (US$ Million) by Application (2020-2025)

Table 65. Global H1N1 Influenza A Vaccine Revenue (US$ Million) by Application (2026-2031)

Table 66. Global H1N1 Influenza A Vaccine Revenue Market Share by Application (2020-2025)

Table 67. Global H1N1 Influenza A Vaccine Revenue Market Share by Application (2026-2031)

Table 68. Global H1N1 Influenza A Vaccine Price (US$/Unit) by Application (2020-2025)

Table 69. Global H1N1 Influenza A Vaccine Price (US$/Unit) by Application (2026-2031)

Table 70. Sanofi Company Information

Table 71. Sanofi Description and Business Overview

Table 72. Sanofi H1N1 Influenza A Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 73. Sanofi H1N1 Influenza A Vaccine Product

Table 74. Sanofi Recent Developments/Updates

Table 75. Beijing Institute of Biological Products Company Information

Table 76. Beijing Institute of Biological Products Description and Business Overview

Table 77. Beijing Institute of Biological Products H1N1 Influenza A Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 78. Beijing Institute of Biological Products H1N1 Influenza A Vaccine Product

Table 79. Beijing Institute of Biological Products Recent Developments/Updates

Table 80. Sinovac Biotech Company Information

Table 81. Sinovac Biotech Description and Business Overview

Table 82. Sinovac Biotech H1N1 Influenza A Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 83. Sinovac Biotech H1N1 Influenza A Vaccine Product

Table 84. Sinovac Biotech Recent Developments/Updates

Table 85. Fosun Yalifeng (Dalian) Biopharmaceutical Company Information

Table 86. Fosun Yalifeng (Dalian) Biopharmaceutical Description and Business Overview

Table 87. Fosun Yalifeng (Dalian) Biopharmaceutical H1N1 Influenza A Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 88. Fosun Yalifeng (Dalian) Biopharmaceutical H1N1 Influenza A Vaccine Product

Table 89. Fosun Yalifeng (Dalian) Biopharmaceutical Recent Developments/Updates

Table 90. Shanghai Institute Of Biological Products Company Information

Table 91. Shanghai Institute Of Biological Products Description and Business Overview

Table 92. Shanghai Institute Of Biological Products H1N1 Influenza A Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 93. Shanghai Institute Of Biological Products H1N1 Influenza A Vaccine Product

Table 94. Shanghai Institute Of Biological Products Recent Developments/Updates

Table 95. Hualan Biological Engineering Company Information

Table 96. Hualan Biological Engineering Description and Business Overview

Table 97. Hualan Biological Engineering H1N1 Influenza A Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 98. Hualan Biological Engineering H1N1 Influenza A Vaccine Product

Table 99. Hualan Biological Engineering Recent Developments/Updates

Table 100. Lanzhou Biological Products Company Information

Table 101. Lanzhou Biological Products Description and Business Overview

Table 102. Lanzhou Biological Products H1N1 Influenza A Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 103. Lanzhou Biological Products H1N1 Influenza A Vaccine Product

Table 104. Lanzhou Biological Products Recent Developments/Updates

Table 105. Key Raw Materials Lists

Table 106. Raw Materials Key Suppliers Lists

Table 107. H1N1 Influenza A Vaccine Distributors List

Table 108. H1N1 Influenza A Vaccine Customers List

Table 109. H1N1 Influenza A Vaccine Market Trends

Table 110. H1N1 Influenza A Vaccine Market Drivers

Table 111. H1N1 Influenza A Vaccine Market Challenges

Table 112. H1N1 Influenza A Vaccine Market Restraints

Table 113. Research Programs/Design for This Report

Table 114. Key Data Information from Secondary Sources

Table 115. Key Data Information from Primary Sources

Table 116. Authors List of This Report

List of Figures

Figure 1. Product Picture of H1N1 Influenza A Vaccine

Figure 2. Global H1N1 Influenza A Vaccine Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global H1N1 Influenza A Vaccine Market Share by Type: 2024 & 2031

Figure 4. 0.5mL/Tube Product Picture

Figure 5. Others Product Picture

Figure 6. Global H1N1 Influenza A Vaccine Market Value by Application (2020-2031) & (US$ Million)

Figure 7. Global H1N1 Influenza A Vaccine Market Share by Application: 2024 & 2031

Figure 8. Underage

Figure 9. Aldult

Figure 10. Global H1N1 Influenza A Vaccine Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 11. Global H1N1 Influenza A Vaccine Market Size (2020-2031) & (US$ Million)

Figure 12. Global H1N1 Influenza A Vaccine Sales (2020-2031) & (K Units)

Figure 13. Global H1N1 Influenza A Vaccine Average Price (US$/Unit) & (2020-2031)

Figure 14. H1N1 Influenza A Vaccine Report Years Considered

Figure 15. H1N1 Influenza A Vaccine Sales Share by Manufacturers in 2024

Figure 16. Global H1N1 Influenza A Vaccine Revenue Share by Manufacturers in 2024

Figure 17. Global 5 and 10 Largest H1N1 Influenza A Vaccine Players: Market Share by Revenue in H1N1 Influenza A Vaccine in 2024

Figure 18. H1N1 Influenza A Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 19. Global H1N1 Influenza A Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 20. North America H1N1 Influenza A Vaccine Sales Market Share by Country (2020-2031)

Figure 21. North America H1N1 Influenza A Vaccine Revenue Market Share by Country (2020-2031)

Figure 22. United States H1N1 Influenza A Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 23. Canada H1N1 Influenza A Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 24. Europe H1N1 Influenza A Vaccine Sales Market Share by Country (2020-2031)

Figure 25. Europe H1N1 Influenza A Vaccine Revenue Market Share by Country (2020-2031)

Figure 26. Germany H1N1 Influenza A Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 27. France H1N1 Influenza A Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 28. U.K. H1N1 Influenza A Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. Italy H1N1 Influenza A Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. Russia H1N1 Influenza A Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Asia Pacific H1N1 Influenza A Vaccine Sales Market Share by Region (2020-2031)

Figure 32. Asia Pacific H1N1 Influenza A Vaccine Revenue Market Share by Region (2020-2031)

Figure 33. China H1N1 Influenza A Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 34. Japan H1N1 Influenza A Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. South Korea H1N1 Influenza A Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. India H1N1 Influenza A Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. Australia H1N1 Influenza A Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. China Taiwan H1N1 Influenza A Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. Southeast Asia H1N1 Influenza A Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Latin America H1N1 Influenza A Vaccine Sales Market Share by Country (2020-2031)

Figure 41. Latin America H1N1 Influenza A Vaccine Revenue Market Share by Country (2020-2031)

Figure 42. Mexico H1N1 Influenza A Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Brazil H1N1 Influenza A Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Argentina H1N1 Influenza A Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Middle East and Africa H1N1 Influenza A Vaccine Sales Market Share by Country (2020-2031)

Figure 46. Middle East and Africa H1N1 Influenza A Vaccine Revenue Market Share by Country (2020-2031)

Figure 47. Turkey H1N1 Influenza A Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Saudi Arabia H1N1 Influenza A Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. UAE H1N1 Influenza A Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Global Sales Market Share of H1N1 Influenza A Vaccine by Type (2020-2031)

Figure 51. Global Revenue Market Share of H1N1 Influenza A Vaccine by Type (2020-2031)

Figure 52. Global H1N1 Influenza A Vaccine Price (US$/Unit) by Type (2020-2031)

Figure 53. Global Sales Market Share of H1N1 Influenza A Vaccine by Application (2020-2031)

Figure 54. Global Revenue Market Share of H1N1 Influenza A Vaccine by Application (2020-2031)

Figure 55. Global H1N1 Influenza A Vaccine Price (US$/Unit) by Application (2020-2031)

Figure 56. H1N1 Influenza A Vaccine Value Chain

Figure 57. Channels of Distribution (Direct Vs Distribution)

Figure 58. Bottom-up and Top-down Approaches for This Report

Figure 59. Data Triangulation

Figure 60. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions